Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Dermira, Inc. (DERM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/30/2020 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds CBB, HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations |
| 01/29/2020 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – HABT, DERM, HXL, PRMW |
| 01/15/2020 |
GN
| DERM, CRCM, LOGM, and WAAS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 01/10/2020 |
GN
| DERMIRA MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Dermira, Inc. is Fair to Shareholders; Investors are Encouraged to Contact the Firm – DERM |
| 04/09/2019 |
GN
| Investor Expectations to Drive Momentum within Dermira, Elanco Animal Health, Ready Capital, Cushman & Wakefield, BlueLinx, and Lydall — Discovering Underlying Factors of Influence |
| 03/24/2019 |
GN
| Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign to Highlight QBREXZA™ (glycopyrronium) Cloth |
| 03/22/2019 |
GN
| Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares |
| 03/19/2019 |
GN
| Dermira Prices $130.0 Million Public Offering of Common Stock |
| 02/22/2019 |
GN
| Dermira Initiates Proof-of-Concept Study to Evaluate QBREXZA™ (glycopyrronium) Cloth in Patients with Primary Palmar Hyperhidrosis |
| 02/12/2019 |
GN
| Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab |
| 12/11/2018 |
GN
| Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 12/04/2018 |
GN
| Dermira Enters into Credit Facility with Athyrium Capital Management |
| 10/23/2018 |
GN
| Dermira Completes Patient Enrollment in Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis |
| 10/09/2018 |
GN
| Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 10/02/2018 |
GN
| Dermira and Christian Siriano Collaborate to Inspire People Living with Excessive Underarm Sweating to Feel Confident in Their Own Skin |
| 10/01/2018 |
GN
| Dermira's QBREXZA™ (glycopyrronium) Cloth Is Now Available in Pharmacies Nationwide for the Treatment of Primary Axillary Hyperhidrosis |
| 09/25/2018 |
GN
| Dermira to Present at Cantor 2018 Global Healthcare Conference |
| 09/13/2018 |
GN
| Dermira Presents New Pediatric Efficacy and Safety Data for Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis at the European Academy of Dermatology and Venereology Congress |
| 09/10/2018 |
GN
| Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 09/05/2018 |
GN
| Dermira Provides Launch Readiness Update for QBREXZA™ (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis |
| 08/20/2018 |
GN
| Report: Exploring Fundamental Drivers Behind MediciNova, Dermira, FRP, BiondVax Pharmaceuticals, The Descartes Systems Group, and American Software — New Horizons, Emerging Trends, and Upcoming Developments |
| 08/08/2018 |
GN
| Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 07/10/2018 |
GN
| Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 06/29/2018 |
GN
| Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis |
| 06/08/2018 |
GN
| Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 06/05/2018 |
GN
| Investor Expectations to Drive Momentum within Dermira, Atlassian, 51job, Sierra Wireless, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, and InterDigital — Discovering Underlying Factors of Influence |
| 05/30/2018 |
GN
| Dermira to Present at Jefferies 2018 Global Healthcare Conference |
| 05/03/2018 |
GN
| Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update |
| 05/01/2018 |
GN
| Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference |
| 04/19/2018 |
GN
| Christopher Horan Joins Dermira as Chief Technical Operations Officer |
| 04/12/2018 |
GN
| Recent Analysis Shows Landmark Infrastructure Partners LP, Laureate Education, MDC Partners, Pzena Investment Management, Dermira, and MediciNova Market Influences — Renewed Outlook, Key Drivers of Growth |
| 04/11/2018 |
GN
| Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 03/20/2018 |
GN
| Dermira to Present at 17th Annual Needham Healthcare Conference |
| 02/17/2018 |
GN
| New Data in Pediatric Patients with Axillary Hyperhidrosis Presented During Late-Breaking Research Forum at the 76th Annual Meeting of the American Academy of Dermatology |
|
|
|